BlackRock Health Sciences Trust (NYSE:BME – Get Free Report) was the target of a significant drop in short interest in November. As of November 30th, there was short interest totalling 6,200 shares, a drop of 56.0% from the November 15th total of 14,100 shares. Based on an average trading volume of 38,100 shares, the short-interest ratio is presently 0.2 days.
Hedge Funds Weigh In On BlackRock Health Sciences Trust
Several large investors have recently added to or reduced their stakes in BME. Fountainhead AM LLC purchased a new position in BlackRock Health Sciences Trust during the third quarter worth approximately $204,000. Wolverine Asset Management LLC raised its position in shares of BlackRock Health Sciences Trust by 42.4% in the 3rd quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock worth $3,588,000 after buying an additional 25,457 shares during the period. Consolidated Portfolio Review Corp raised its position in shares of BlackRock Health Sciences Trust by 7.2% in the 3rd quarter. Consolidated Portfolio Review Corp now owns 42,574 shares of the company’s stock worth $1,785,000 after buying an additional 2,853 shares during the period. International Assets Investment Management LLC purchased a new stake in BlackRock Health Sciences Trust during the third quarter valued at about $8,610,000. Finally, Logan Stone Capital LLC purchased a new position in shares of BlackRock Health Sciences Trust in the 2nd quarter worth about $600,000.
BlackRock Health Sciences Trust Trading Up 0.2 %
NYSE:BME opened at $38.68 on Friday. BlackRock Health Sciences Trust has a 12-month low of $38.00 and a 12-month high of $42.86. The stock has a fifty day moving average price of $40.25 and a 200 day moving average price of $40.83.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Trust
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Quiet Period Expirations Explained
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Consumer Discretionary Stocks Explained
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.